Document:

EX-10.23

 Exhibit 10.23 

SUPPLY AGREEMENT 
 This
Supply Agreement (this “Agreement”) is made and entered into as of August 15, 2018 (the “Effective Date”) by and between NantCell, Inc. (“NantCell”) and NantBio, Inc. (formerly named
NantBioScience, Inc.) (together with its subsidiaries, including for the avoidance of doubt, NantCancerStemCell, LLC, “Buyer”). NantCell and Buyer may be referred to in this Agreement individually as a “Party” and
collectively as the “Parties.” 
 1.    EQUIPMENT AND CONSUMABLES ORDERS 

1.1    Development Activities. NantCell shall conduct mutually agreed development activities to modify and
optimize its bioreactor incorporating next-generation proprietary technology called “GMP in a box” as may be appropriate to allow the use of such bioreactor to produce/generate (a) stem cells and/or (b) novel protein based
therapies, including antibodies (“Development Activities”). The specific Development Activities to be conducted by NantCell shall be mutually agreed in writing by the Parties and shall be designed to result in a set of mutually
agreed specifications for the version of such bioreactor that would be purchased by Buyer from NantCell under this Agreement. If NantCell requires access to any cell lines or other materials of Buyer in connection with the Development Activities,
such cell lines or materials will be provided by Buyer under a mutually agreed material transfer agreement. 

1.2    Equipment; Consumables. Buyer agrees to purchase from NantCell, and NantCell agrees to manufacture and sell
to Buyer, (a) bioreactors incorporating next-generation proprietary technology called “GMP in a box,” that have been optimized to produce/generate stem cells and/or novel protein based therapies, including antibodies, as a result of
the Development Activities and that conform to specifications that are mutually agreed by the Parties in writing (the “Equipment”) and (b) reagents/consumables needed for the use of the Equipment
(“Consumables”). NantCell shall also provide to Buyer: (i) reasonably detailed, accurate, written instruction manuals with respect to the operation and use of the Equipment and Consumables purchased by Buyer; and (ii) upon
request and at Buyer’s facilities, initial training on the operation and use of the Equipment. In addition, NantCell hereby grants to Buyer a perpetual, non-assignable,
non-sublicenseable, non-exclusive, royalty-free, fully paid-up, worldwide license to use and otherwise exploit the bioreactor
software, with access to updates to the bioreactor software during the warranty period. Further, if requested by Buyer, NantCell will negotiate in good faith and enter into an agreement with Buyer for the provision of ongoing maintenance services
for the Equipment following the applicable warranty period. Promptly following completion of the Development Activities and mutual agreement by the Parties on specifications for the Equipment, NantCell shall provide to Buyer a list of the
Consumables and may update such list from time to time upon written notice to Buyer. 
 1.3    Orders. When Buyer
wishes to purchase Equipment and/or Consumables, Buyer may submit purchase orders (“Purchase Orders”) to NantCell that specify: (a) the number of units and (b) the requested delivery date, which will be consistent with
NantCell’s standard minimum lead time for the Equipment and Consumables. Upon completion of the Development Activities and the Parties’ mutual agreement on specifications for the Equipment, and monthly thereafter, Buyer shall provide
NantCell with a rolling, good faith twelve (12) month forecast of Buyer’s 

 
quantity and shipment needs for Equipment and Consumables. On or about the fifteenth (15th) day of each month, Buyer shall provide to NantCell with an updated forecast covering an additional
month. NantCell shall use commercially reasonable efforts to maintain the capability to supply Equipment and Consumables consistent with such Buyer forecasts and to accept all Purchase Orders submitted to NantCell in accordance with this
Article 1 and consistent with such forecasts, which acceptance may be made by sending Buyer a written or electronic order acknowledgment (“Order Acknowledgment”) or by delivering the Equipment units or Consumables specified in
the Purchase Order. For the purposes of this Agreement, a Purchase Order accepted by NantCell will be referred to in this Agreement as an “Order,” and the “Scheduled Delivery Date” for each Order will be the
delivery date specified in the applicable Order Acknowledgment, provided that such date shall be the same as Buyer’s requested delivery date in the corresponding Purchase Order, unless otherwise mutually agreed by the Parties. 

1.4    Order Changes. Orders are non-cancellable, except with respect to
any Equipment and Consumables specified in the corresponding Purchase Order that are not delivered to Buyer within thirty (30) days of the Scheduled Delivery Date if, following good faith discussions, the Parties are unable to agree on a
revised Scheduled Delivery Date. However, Buyer may reschedule delivery of any Order thirty (30) days or more prior to the Scheduled Delivery Date of the Order; provided, that in no event will delivery of any Order be rescheduled for a date
that is more than sixty (60) days after the original Scheduled Delivery Date and in no event will delivery of any Order be rescheduled more than once. 

1.5    Agreement Controls. The terms and conditions of this Agreement will apply to any and all Orders, and will
prevail over and supersede any terms and conditions of any Purchase Order, Order Acknowledgement or other document not executed in writing by both Parties that are in addition to or inconsistent with the terms and conditions of this Agreement. Such
additional and inconsistent terms and conditions are hereby rejected and will have no force or effect, notwithstanding acceptance of or performance under such Purchase Order, Order Acknowledgement or other document. To the extent that the terms and
conditions of this Agreement constitute an offer by NantCell, acceptance of such offer is expressly limited to the terms and conditions of this Agreement. 

2.    PRICING & PAYMENT 

2.1    Pricing. For each unit of Equipment and/or Consumables purchased by Buyer under this Agreement, Buyer shall
pay to NantCell the amount set forth on Exhibit A. The amounts specified on Exhibit A do not include any federal, state, local or other taxes (including sales, use, excise, value-added,
import, export or other taxes) applicable to any Equipment or Consumables or any payments made or owed by Buyer to NantCell (collectively, “Taxes”). Buyer will pay or reimburse NantCell for all Taxes; provided, that Buyer will have
no responsibility for taxes imposed on NantCell’s or any of its affiliates’ net income. If a transaction is exempt from any Taxes, Buyer will provide NantCell with a valid exemption certificate or other evidence of such exemption in a form
reasonably acceptable to NantCell. NantCell may, from time to time upon at least 30 days’ prior written notice to Buyer, increase the pricing on Exhibit A to reflect/account for changes in costs, market conditions, etc. 

  
 2 

 2.2    Payment terms. Unless otherwise agreed by the Parties,
NantCell shall invoice Buyer (a) on a monthly or quarterly basis (at NantCell’s option), for NantCell’s costs incurred in performance of the Development Activities in accordance with the mutually agreed budget therefor; and
(b) for a particular Order, for the Equipment and Consumables upon shipment. Amounts invoiced hereunder will be due and payable thirty (30) days from the date of invoice. Buyer will make all payments in U.S. dollars (unless otherwise
mutually agreed) by bank wire transfer or other means satisfactory to NantCell, and all fees and costs associated with payment by wire transfer or other means will be the responsibility of Buyer. If any portion of an Order is delivered
without the remainder of such Order, such delivery will be considered a separate and independent transaction. Accordingly, NantCell will be deemed to have fully performed its obligations with respect to such portion, and Buyer’s payment
obligations with respect to such portion will accrue upon delivery thereof in accordance with Section 1.4 above. 

2.3    Security Interest. NantCell reserves, and Buyer hereby grants and agrees to grant to NantCell, a security
interest (which in jurisdictions outside of the United States will be a fixed charge or analogous interest under applicable local laws) (“Security Interest”) in any Equipment sold to the extent of the relevant invoiced amount.
Pending the payment of such invoiced amount in full, Buyer will not sell, encumber, lease or otherwise deal with the Equipment without NantCell’s prior written consent; provided that the foregoing shall not prevent or limit Buyer’s rights
to transfer any Equipment to a permitted assignee of this Agreement. If Buyer defaults on any payment for any Equipment that is not disputed by Buyer in good faith, Buyer agrees to make such Equipment available so that NantCell can repossess it
without a breach of the peace. A copy of the invoice may be filed with appropriate authorities at any time as a financing statement. Upon Buyer’s payment for a particular unit of Equipment, NantCell shall promptly release any such Security
Interest and record such release. Without limiting the foregoing, upon a Party’s request, the other Party will take all appropriate steps and execute any documents to perfect or release, as applicable, NantCell’s Security Interest in any
Equipment. 
 2.4    Records; Audits. NantCell shall maintain complete and accurate accounting records related
its costs with respect to the Development Activities, Equipment and/or Consumables in accordance with generally accepted accounting principles in the United States. These records shall be available for inspection, review and audit at reasonable
times, but no more than once per calendar year, by Buyer or, if required by NantCell or requested by Buyer, its duly authorized representative that is reasonably acceptable to NantCell and that executes a written confidentiality agreement with
NantCell, for three (3) years following the end of the calendar year in which such costs are invoiced. If any audit establishes an overpayment by Buyer, the amount of such overpayment shall promptly be reimbursed to Buyer by NantCell. Audits
under this Section 2.4 shall be conducted at Buyer’s expense, unless a discrepancy in favor of Buyer of more than five percent (5%) of the payments made hereunder for the period being audited is established, in which event NantCell shall
pay Buyer’s reasonable out-of-pocket costs in connection with such audit. 

3.    DELIVERY 

3.1    Delivery Terms. Equipment and Consumables will be delivered FCA (Incoterms 2010) NantCell’s United
States facility or NantCell’s contractor’s United States facility, as 

  
 3 

 
specified by NantCell, unless otherwise specified in any Order Acknowledgments. Title to Equipment will pass to Buyer upon delivery to the carrier. Buyer will not refuse or otherwise fail
to take delivery of any Orders delivered in accordance with Section 1.4 above. NantCell shall exercise commercially reasonable efforts to deliver Equipment and/or Consumables within the relevant period specified in Section 1.4 above. In
the event that NantCell’s ability to supply Equipment and/or Consumables becomes constrained, NantCell may reduce quantities or allocate capacity among its customers at its reasonable discretion, provided that NantCell shall promptly notify
Buyer of the same and Buyer may terminate by written notice any Order for Equipment and/or Consumables that NantCell is unable to fulfill in accordance with Section 1.4 above. 

3.2    Product Modifications. NantCell may modify design or manufacture of the Equipment and/or Consumables,
provided that such Equipment and Consumables continue to conform in all material respects to the mutually agreed specifications for such Equipment and Consumables; provided further that NantCell shall not make any such changes that may affect a
regulatory filing made by or under the authority of Buyer without Buyer’s prior written consent (which shall not be unreasonably withheld). 

4.    ACCEPTANCE AND WARRANTY 

4.1    Acceptance. Equipment and Consumables will be deemed accepted by Buyer upon delivery thereof, subject to the
warranty provisions set forth in this Section 4. 
 4.2    Limited Warranty. 

(a)    NantCell warrants to Buyer that: (i) it will transfer to Buyer all Equipment and Consumables ordered by Buyer
pursuant to an Order, free and clear of any liens or encumbrances and (ii) during the Warranty Period (defined below) (1) each Equipment unit or Consumable unit (in the form delivered by NantCell), as applicable, will comply with
applicable mutually agreed upon specifications set forth in a writing signed by an authorized representative of each Party and (2) each Equipment unit will be free from material defects in material and workmanship under proper use, service and
conditions. The foregoing warranty is referred to in this Agreement as the “Equipment/Consumable Warranty” and, notwithstanding anything herein to the contrary, with respect to Consumables, expires as soon as the Consumable
is partly or fully used or consumed. The “Warranty Period” for (i) each Equipment unit will have a duration of twelve (12) months; and (ii) for each unit of Consumable, will have a duration of thirty (30) days;
in each case, commencing the date of delivery of the applicable unit to Buyer. 
 (c)    Notwithstanding anything herein
to the contrary, the Equipment/Consumable Warranty will not apply to (i) Equipment or Consumable units that are provided as samples, design verification units or prototypes, or similar designated units or (ii) defects, failures or other
nonconformities attributable to (1) accident, abuse, misuse, neglect, alteration, improper installation, improper storage, repair or improper testing involving such unit other than by NantCell, (2) use of such unit contrary to
NantCell’s reasonable written instructions or (3) any items not (i) furnished by NantCell, (ii) constituting stem cells and/or novel protein based therapies, including antibodies, for which the Equipment or Consumable is designed
to be 

  
 4 

 
used or (iii) otherwise authorized by NantCell for use by Buyer in, or in connection with, the Equipment. 

4.3    Warranty Remedies. If any Equipment or Consumable unit fails to comply with the Equipment/Consumable
Warranty during the applicable Warranty Period, NantCell will, at its option, repair or replace such unit, or issue a refund to Buyer for the actual purchase price of such unit, in each case upon receiving return of such unit from Buyer; provided
that, during the applicable Warranty Period, Buyer notifies NantCell in writing of such failure and, to the extent reasonably discernible by Buyer, provides NantCell a reasonably detailed description of such failure. Buyer will not return any
Equipment unit without first obtaining a return material authorization from NantCell. Each repaired or replacement Equipment unit will be covered by the Equipment/Consumable Warranty for the remainder of the Warranty Period of the original Equipment
unit. 
 4.4    Sole Remedy. EXCEPT FOR WARRANTY VIOLATIONS ARISING FROM THE GROSS NEGLIGENCE OR WILLFUL
MISCONDUCT OF NANTCELL, NANTCELL’S INDEMNIFICATION OBLIGATIONS IN SECTION 7 AND BUYER’S TERMINATION RIGHTS HEREUNDER, SECTION 4.3 SETS FORTH NANTCELL’S SOLE AND EXCLUSIVE LIABILITY AND OBLIGATION, AND BUYER’S SOLE AND EXCLUSIVE
REMEDY, FOR ANY FAILURE OF ANY EQUIPMENT TO CONFORM TO THE EQUIPMENT WARRANTY. 
 4.5    Disclaimers. THE
EQUIPMENT/CONSUMABLE WARRANTY IS EXCLUSIVE AND IN LIEU OF ALL OTHER WARRANTIES BY NANTCELL UNDER OR RELATING TO THIS AGREEMENT (INCLUDING WITH RESPECT TO THE EQUIPMENT AND CONSUMABLES). NEITHER PARTY MAKES, AND EACH PARTY HEREBY EXPRESSLY DISCLAIMS,
ANY OTHER REPRESENTATIONS OR WARRANTIES (WHETHER EXPRESS, IMPLIED, STATUTORY OR OTHERWISE) IN CONNECTION WITH ANY EQUIPMENT OR CONSUMABLES OR ANY OTHER ASPECTS OF THIS AGREEMENT, INCLUDING ANY IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR ANY
PARTICULAR PURPOSE, ACCURACY, NON-INFRINGEMENT OF THIRD PARTY RIGHTS OR TITLE, AND ANY WARRANTIES THAT MAY ARISE FROM COURSE OF DEALING, COURSE OF PERFORMANCE OR USAGE OF TRADE. FURTHER, BUYER WILL BE
RESPONSIBLE FOR ENSURING THAT: (I) THE EQUIPMENT AND CONSUMABLES (PROVIDED SUCH ITEM COMPLIES WITH APPLICABLE SPECIFICATIONS WHEN DELIVERED) ARE SUITABLE FOR BUYER’S INTENDED USE; (II) THE EQUIPMENT AND CONSUMABLES ARE HANDLED IN A
SAFE MANNER AND (III) BUYER’S USE OF THE EQUIPMENT AND CONSUMABLES, AND ANY DEVICES AND OTHER MATERIALS PROVIDED BY BUYER FOR USE IN CONNECTION WITH THE EQUIPMENT, COMPLY WITH RELEVANT NATIONAL AND INTERNATIONAL SAFETY REGULATIONS. 

5.     CONFIDENTIALITY. 

5.1    Confidential Information. “Confidential Information” means any non-public, proprietary or confidential information or material of a Party that (i) is disclosed in writing and is 

  
 5 

 
clearly marked as “confidential” or with a similar proprietary notice at the time of disclosure; (ii) is disclosed verbally and identified as “confidential” or similarly
at the time of disclosure, or (iii) by its nature, a reasonable person would consider confidential. If Confidential Information is disclosed or otherwise made available by a Party (the “Disclosing Party”) to the other party
(the “Receiving Party”), the Receiving Party shall use such Confidential Information only for the purpose for which it was provided (including such Party’s exercise of its rights hereunder) or as otherwise agreed to in writing
and not disclose such Confidential Information to any person or entity (except to its affiliates and its and their respective officers, directors, employees, agents and contractors that are bound by written nondisclosure agreements or obligations as
least as protective as the terms and conditions of this Section 5). The terms and conditions of this Agreement shall be Confidential Information of both parties and disclosure of all or any part thereof to any third party or the public shall be
upon consent of both Parties hereto; provided that either Party may disclose this Agreement (a) to its accountants, attorneys and other professional advisers, and to actual and potential investors, acquirers and others on a need to know basis,
subject to appropriate confidentiality obligations and (b) as required by law, legal requirement (including applicable securities laws), regulation, judicial process or order consistent with Section 5.2(v) below. 

5.2    Exceptions. The obligations of each Party under this Section 5 with respect to the other party’s
Confidential Information shall not apply to Confidential Information that the Receiving Party can prove: (i) becomes publicly available through no fault of the Receiving Party; (ii) is or becomes available to the Receiving Party or its
affiliates on a non-confidential basis from a third party; provided, that such third party is not and was not prohibited by the Disclosing Party from disclosing the Confidential Information; (iii) was
already known by or in the possession of the Receiving Party or its affiliates; (iv) is independently developed or received by the Receiving Party or its affiliates without reference to or use of the Disclosing Party’s Confidential
Information; or (v) is subject to disclosure by law, legal requirement, regulation, judicial process or order, in which case, if permitted by law, the Receiving Party shall use reasonable efforts to provide written notice to the Disclosing
Party of its obligation to disclose such Confidential Information with an opportunity to seek for the Disclosing Party to object. 

6.    RESERVATION OF RIGHTS; RESTRICTIONS; EMBEDDED SOFTWARE 

6.1    The manufacture by NantCell of Equipment and Consumables for Buyer shall not be deemed to give to Buyer any
intellectual property interest in any Equipment, Consumables or any portion of any design relating to any Equipment or Consumables. Buyer acknowledges and agrees that NantCell retains and shall own all right, title and interest in and to all
intellectual property rights with respect to the Equipment, Consumables and any discoveries, inventions or improvements pertaining to the Equipment or Consumables developed or made by NantCell solely, or with others, in connection with this
Agreement. Buyer shall retain all rights in and to its technology and intellectual property (including without limitation all intellectual property rights relating to Buyer’s proprietary materials) and any discoveries, inventions or
improvements pertaining to such Buyer technology and/or intellectual property developed or made in connection with this Agreement. 

6.2    If the Equipment includes embedded/preinstalled software (e.g., firmware), Buyer is hereby granted a non-exclusive, non-transferable license to use such software solely in object code format as installed by NantCell and solely for its own internal use of the Equipment,
subject to the 

  
 6 

 
terms contained herein. Buyer shall not (i) use the software for purposes other than those for which it was designed; (ii) use the software in connection with other products/devices
unless such connectivity is authorized by NantCell; (iii) grant, assign, transfer, or otherwise make available to third parties any right in the software; (iv) copy or reproduce the software (except as may otherwise be permitted by
applicable law); (v) alter or modify the software; or (vi) reverse engineer, decompile, disassemble or create any derivative works based upon the software except as expressly permitted by law. 

6.3    Buyer agrees (a) to use each Consumable only one time; and (b) to use only NantCell’s Consumable
with the Equipment. In addition, Buyer agrees not to, nor authorize any third party to, engage in any of the following activities: (i) disassemble, reverse-engineer, reverse-compile or reverse-assemble the Equipment; (ii) separate, extract
or isolate components of the Equipment and/or Consumables or subject the Equipment or Consumables or components thereof to any analysis not expressly authorized in writing by NantCell; or (iii) gain access to or attempt to determine the methods
of operation of the Equipment (provided that, if any such information is necessary for Buyer’s qualification of the Equipment and/or Consumables for a regulatory purpose, NantCell shall cooperate with Buyer to provide such information). Buyer
further agrees that the contents of the Equipment and Consumables and methods of operation of the Equipment are proprietary to NantCell and the Equipment and Consumables contain or embody trade secrets of NantCell. 

7.    INDEMNIFICATION 

7.1    Indemnity from NantCell. NantCell will defend Buyer and its directors, officers, employees and agents from,
or settle, any suit that may be instituted by a third party against Buyer to the extent based on (a) a claim that any Equipment or Consumables sold by NantCell to Buyer under this Agreement, as and in the form provided by NantCell to Buyer,
infringes any patent, trademark, copyright and/or other proprietary right; or (b) bodily harm, injury or death resulting from NantCell’s or any of its affiliates’ gross negligence or willful malfeasance; except to the extent such
claim (under (a) or (b) above) is the result of Buyer’s negligence, willful misconduct or material breach of this Agreement. In addition, NantCell will pay any damages finally awarded against Buyer in such suit for such a claim.
Notwithstanding the foregoing, the obligations of NantCell in this Section 7.1 will not apply to the extent that the alleged infringement or claim thereof pertains to (i) the combination or use of any Equipment or Consumable with hardware,
software, data or other materials not provided, required or authorized by NantCell, (ii) use of any Equipment other than for its intended purpose, (iii) modifications or additions to any Equipment not made, required or authorized by
NantCell, or (iv) compliance with any designs, specifications or instructions of Buyer specific to the use of the Equipment for the production/generation of stem cells and/or novel protein based therapies, including antibodies, that do not
provide NantCell with the flexibility to provide a non-infringing alternative (subsections (i)-(iv) collectively, “Excluded Activities”). 

7.2     NantCell Options. In satisfaction of Section 7.1, NantCell may, at its sole discretion,
(a) replace or modify any allegedly infringing Equipment or Consumables with non-infringing, functionally equivalent devices or materials, as applicable, (b) obtain a license for Buyer to continue
the use of such Equipment or Consumables or (c) if neither of the foregoing is 

  
 7 

 
reasonably practicable, accept the return of units of such Equipment or Consumables and refund the amount paid by the Buyer for such returned units (minus, in the case of the Equipment only,
depreciation on a three-year basis (one-third of the applicable purchase price for each year or portion thereof after the purchase of the Equipment)). 

7.3    Indemnity from Buyer. Buyer will defend NantCell and its directors, officers, employees and agents from, or
settle, any suit that may be instituted by a third party against NantCell to the extent based on any Excluded Activity. In addition, Buyer will pay any damages finally awarded against NantCell in such suit for such claim. 

7.4    Indemnification Conditions. Notwithstanding anything herein to the contrary, the obligations of each of
NantCell and Buyer (“Indemnifying Party”) to the other Party (“Indemnified Party”) under Section 7.1 or 7.3, as applicable, will be conditioned upon and subject to the Indemnified Party giving the Indemnifying
Party (a) prompt notice in writing of the applicable suit (but the failure of Indemnified Party to promptly provide notice shall not relieve the Indemnifying Party of its indemnification obligations hereunder except to the extent materially
prejudiced thereby), (b) sole control of the defense and settlement of such suit, and (c) all information, assistance and authority reasonably requested by Indemnifying Party in connection with the defense or settlement of such suit. 

7.5    Sole Remedy. SECTIONS 7.1 AND 7.2 SET FORTH NANTCELL’S SOLE AND EXCLUSIVE LIABILITY AND OBLIGATION, AND
BUYER’S SOLE AND EXCLUSIVE REMEDY, FOR ANY ACTUAL OR ALLEGED INFRINGEMENT, MISAPPROPRIATION OR OTHER VIOLATION OF ANY THIRD PARTY PATENT, TRADEMARK, COPYRIGHT, TRADE SECRET OR OTHER THIRD PARTY INTELLECTUAL PROPERTY RIGHT BY ANY EQUIPMENT OR BY
ANY ACTIVITIES OF NANTCELL UNDER THIS AGREEMENT. SECTION 7.3 SETS FORTH BUYER’S SOLE AND EXCLUSIVE LIABILITY AND OBLIGATION, AND NANTCELL’S SOLE AND EXCLUSIVE REMEDY, FOR ANY ACTUAL OR ALLEGED INFRINGEMENT, MISAPPROPRIATION OR OTHER
VIOLATION OF ANY THIRD PARTY PATENT, TRADEMARK, COPYRIGHT OR OTHER THIRD PARTY INTELLECTUAL PROPERTY RIGHTS BY ANY ACTIVITIES OF BUYER UNDER THIS AGREEMENT. 

8.    TERM AND TERMINATION 

8.1    Term and Termination. The term of this Agreement shall commence on the Effective Date and continue for a term
of five (5) years. Thereafter, the term of this Agreement will automatically renew for additional successive one (1) periods terms unless and until this Agreement is terminated in accordance with this Section 8. This Agreement may be
terminated by either Party in the event of a material default by the other, provided that written notice of such default and the intent to terminate has been given to the defaulting Party and such default has not been remedied to the reasonable
satisfaction of the non-defaulting Party within thirty (30) days of delivery of such notice. In addition, Buyer may terminate this Agreement for any reason upon ninety (90) days prior written notice
to NantCell. 

  
 8 

 8.2    Effect of Termination. Upon any expiration or termination
of this Agreement, any Orders that are outstanding as of such expiration or termination will remain in effect, and the terms and conditions of this Agreement will survive with respect to each such Order until it is delivered. Notwithstanding the
foregoing, either Party may terminate any or all such outstanding Orders if this Agreement is terminated by such Party pursuant to Section 8.1 for the other Party’s material default. In any event, the rights and obligations of the Parties
under Sections 2, 4.2-4.4 (solely with respect to any Equipment unit for which the Warranty Period has not expired, and solely for the remainder of such Warranty Period), 4.5, 5, 6, 7, 8.2, 9, 10 and 11
will survive any expiration or termination of this Agreement. For avoidance of doubt, no expiration or termination of this Agreement will waive, discharge or otherwise affect any payment obligations or other liabilities of the Parties that accrued,
or are attributable to a period, prior to such expiration or termination. 
 9.    LIMITATION OF LIABILITY 

9.1    TO THE EXTENT PERMITTED BY APPLICABLE LAW AND NOTWITHSTANDING ANYTHING IN THIS AGREEMENT TO THE CONTRARY, IN NO
EVENT WILL EITHER PARTY BE LIABLE TO THE OTHER PARTY OR ANY THIRD PARTY (WHETHER SUCH LIABILITY IS BASED ON CONTRACT, WARRANTY, NEGLIGENCE, STRICT LIABILITY, OTHER TORT THEORY, OR ANY OTHER BASIS WHATSOEVER) FOR ANY SPECIAL, INCIDENTAL, EXEMPLARY,
CONSEQUENTIAL OR INDIRECT DAMAGES, OR FOR ANY DAMAGES FOR LOSS OR INTERRUPTION OF BUSINESS, LOSS OF PROFITS OR LOSS OF DATA, ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE SUBJECT MATTER HEREOF, EVEN IF SUCH PARTY HAS BEEN ADVISED OF OR SHOULD
HAVE KNOWN OF THE POSSIBILITY OF SUCH DAMAGES; PROVIDED HOWEVER THAT NOTHING IN THIS SECTION 9.1 SHALL BE DEEMED TO LIMIT THE INDEMNIFICATION OBLIGATIONS OF EITHER PARTY UNDER ARTICLE 7 TO THE EXTENT THE THIRD PARTY CLAIMANT IS FINALLY AWARDED ANY
PUNITIVE, SPECIAL, CONSEQUENTIAL, INCIDENTAL OR INDIRECT DAMAGES FROM AN INDEMNITEE. 
 9.2    TO THE EXTENT PERMITTED
BY APPLICABLE LAW AND NOTWITHSTANDING ANYTHING IN THIS AGREEMENT TO THE CONTRARY, IN NO EVENT WILL EITHER PARTY’S TOTAL LIABILITY ARISING OUT OF OR RELATED TO THIS AGREEMENT OR THE SUBJECT MATTER HEREOF (OTHER THAN LIABILITY FOR PAYMENTS OWED
TO NANTCELL IN ACCORDANCE WITH SECTIONS 2.1 AND 2.2 FOR EQUIPMENT AND CONSUMABLES), WHETHER SUCH LIABILITY IS BASED ON CONTRACT, WARRANTY, NEGLIGENCE, STRICT LIABILITY, OTHER TORT THEORY, OR ANY OTHER BASIS WHATSOEVER, EXCEED THE AGGREGATE OF ALL
AMOUNTS PAID BY BUYER TO NANTCELL UNDER THIS AGREEMENT DURING THE TWELVE (12) MONTHS PRECEDING THE MOST RECENT EVENT GIVING RISE TO SUCH LIABILITY; PROVIDED HOWEVER THAT NOTHING IN THIS SECTION 9.2 SHALL BE DEEMED TO LIMIT THE INDEMNIFICATION
OBLIGATIONS OF EITHER PARTY UNDER ARTICLE 7 ABOVE WITH RESPECT TO DAMAGES FINALLY AWARDED TO A THIRD PARTY CLAIMANT, SETTLEMENT AMOUNTS AGREED TO BY THE INDEMNIFYING PARTY AND/OR ANY COSTS OF DEFENSE (INCLUDING WITHOUT LIMITATION REASONABLE
ATTORNEYS’ FEES, EXPENSES TO DEFEND 

  
 9 

 
AND AMOUNTS PAID IN SETTLEMENT OF ANY ACTION) THAT SUCH INDEMNIFYING PARTY IS OBLIGATED TO PAY UNDER SECTION 7. 

10.    RELATIONSHIP OF THE PARTIES 
 In
performing hereunder, NantCell is acting as an independent contractor. In no event shall this Agreement be construed as establishing a partnership or joint venture or similar relationship between the Parties, and nothing herein contained shall be
construed to authorize either Party to act as agent for the other. 
 11.    GENERAL 

11.1    Notices. All notices required to be in writing shall be deemed to have been given either at the time of
delivery if delivered personally or by an independent contract carrier; or twenty-four (24) hours after the time of postmark if mailed Express Mail, postage prepaid, return receipt requested, or three (3) days after the time of postmark if
mailed registered or certified mail, postage prepaid, return receipt requested, and in each case, addressed as set forth below: 
 To
NantCell: 
 NantCell, Inc. 

9920 Jefferson Boulevard 

Culver City, California 90232 

Attn: Chief Executive Officer 

With a copy to: 
 NantCell,
Inc. 
 9920 Jefferson Boulevard 

Culver City, California 90232 

Attn: General Counsel 
 To
Buyer: 
 NantBio, Inc. 

9920 Jefferson Boulevard 

Culver City, California 90232 

Attn: Chief Executive Officer 

With a copy to: 
 NantBio,
Inc. 
 9920 Jefferson Boulevard 

Culver City, California 90232 

Attn: General Counsel 

  
 10 

 or to such other address as any Party shall designate at any time in writing by notice to the other party in
accordance with this paragraph. 
 11.2    Governing Law. This Agreement shall be interpreted and construed in
accordance with the laws of the State of California, without application of any principles of choice of laws. 
 11.3
    Nonwaiver. A waiver by either Party of any breach of this Agreement shall not be binding upon the waiving Party unless such waiver is in writing. In the event of a written waiver, such a waiver shall not affect the
waiving Party’s rights with respect to any other or further breach. 
 11.4     Execution by Counterpart.
This Agreement may be executed separately or independently in any number of counterparts, by original or facsimile signature, each and all of which together shall be deemed to have been executed simultaneously and for all purposes to be one
Agreement. Signatures to this Agreement delivered by facsimile or other electronic transmission (e.g., portable document format (PDF)) shall be deemed to be binding as original signatures. 

11.5     Section Headings. The section and subsection headings in this Agreement are included for convenience only
and shall not in any way effect the interpretation or construction of any provision hereof. 
 11.6     Force
Majeure. If by reason of labor disputes, strikes, lockouts, embargo, riots, war, inability to obtain labor, materials or transportation facilities, earthquake, fire or other action of the elements, accidents, governmental restrictions,
appropriation, compliance with any law, regulation or other governmental order or any other causes beyond the control of a Party hereto, either Party is unable to perform in whole or in part its obligations as set forth in this Agreement, excluding
any obligations to make payments hereunder, then such Party will be relieved of those obligations to the extent it is so unable to perform and such inability to perform will not make such Party liable to the other Party. Neither Party will be liable
for any losses, injury, delay or damages suffered or incurred by the other party due to the above causes. 
 11.7
    Entire Agreement; Successors in Interest; Assignment. This Agreement contains the entire Agreement of the Parties with respect to the subject matter hereof. This Agreement shall be binding upon and inure to the benefit
of the successors and assigns of the Parties. Neither Party may assign or otherwise transfer this Agreement or any of its rights under this Agreement, in each case whether voluntarily or involuntarily, without the other Party’s prior written
consent, which will not be unreasonably withheld, conditioned, or delayed; provided, however, that either Party may assign this Agreement to (a) any of its affiliates or (b) to a party that succeeds to all or substantially all of the
assigning Party’s business or assets to which this Agreement relates (whether by merger, sale of stock or assets, consolidation, change of control or otherwise). Any assignment or other transfer without such prior written consent will be null
and void. NantCell may subcontract its obligations under this Agreement to a third party, provided that NantCell informs Buyer prior to using any material subcontractor that is not a NantCell affiliate, provides Buyer with all information reasonably
required by Buyer to satisfy Buyer’s regulatory reporting obligations and NantCell will remain responsible to Buyer for any performance of its obligations hereunder notwithstanding the engagement of any such third party. For purposes of this

  
 11 

 
Agreement: (i) “affiliate” means, with respect to a specified entity, at any time, an entity that, directly or indirectly, through one or more intermediaries, controls, or is
controlled by, or is under common control with, such specified entity at such time; (ii) “subsidiary” means, with respect to a specified entity, at any time, an entity that is, directly or indirectly, through one or more
intermediaries, controlled by such specified entity at such time; and (iii) “control,” when used with respect to any specified entity, means: (1) the direct or indirect ownership of more than fifty percent (50%) (or such lesser
percentage which is the maximum allowed to be owned by a foreign corporation in a particular jurisdiction) of the voting stock or other ownership interest in such specified entity; or (2) to possess, directly or indirectly, the power to
affirmatively direct or cause the direction of the management and policies of such specified entity, whether through ownership of voting securities, by contract relating to voting rights or otherwise; and the terms “controlling” and
“controlled” have meanings correlative to the foregoing. In addition, for the avoidance of doubt, for purposes of this Agreement, Buyer shall not be deemed an affiliate of NantCell and NantCell shall not be deemed an affiliate of Buyer.

 11.8    Export Laws. Buyer represents itself to be knowledgeable as to the laws, regulations and requirements
of the United States and other relevant jurisdictions regarding the export or re-export of products, whether tangible or intangible. Buyer will conduct its activities in accordance with such laws, regulations
and requirements. NantCell may suspend performance if Buyer is in violation of any such laws, regulations or requirements. 

[Signature Page Follows] 

  
 12 

 IN WITNESS WHEREOF, the Parties hereto have executed this Supply Agreement as of the Effective Date. 

 

			
	NANTCELL, INC.
	(“NantCell”)
		
	By:	 	 /s/ Robert Morse

	Name:	 	Robert Morse
	Title:	 	Chief Financial Officer
	
	 NANTBIO, INC.

(“Buyer”)

	By:	 	 /s/ Charles Kim

	Name:	 	Charles Kim
	Title:	 	General Counsel

  
 13EX-10.24

 Exhibit 10.24 

SHARED SERVICES AGREEMENT 

This SHARED SERVICES AGREEMENT (this “Agreement”), dated as of April 4, 2019, but made effective January 1, 2018
(the “Effective Date”), is made by and between NantBio, Inc., a Delaware corporation (“NantBio”), and NantCell, Inc., a Delaware corporation (the “Company”). Each of NantBio and the Company is
sometimes referred to as a “Party” and collectively are sometimes referred to as the “Parties.” In consideration of the mutual promises and covenants set forth herein, and other good and valuable consideration, the
receipt and sufficiency of which are hereby acknowledged, the Parties hereby agree as follows: 
 ARTICLE I 

DEFINITIONS 
 In addition to terms
defined elsewhere in this Agreement, the following terms shall have the following meanings: 
 “Affiliate” means, with
respect to any person, any other person, directly or indirectly, through one or more intermediaries, controlling, controlled by, or under common control with such person. The term “control,” as used in the immediately preceding sentence
means, with respect to any person, the possession, directly or indirectly, of the power to direct or cause the direction of the management or policies of the controlled person. 

ARTICLE II 
 AGREEMENT TO PROVIDE
AND ACCEPT SERVICES 
 Section 2.01.    Provision of Services. On the terms and subject to the conditions
contained in this Agreement, NantBio shall provide, or shall cause its Affiliates or independent contractor third parties contractually designated by it (such designated Affiliates and independent contractors (other than the Company),
together with NantBio, referred to singly as a “Service Provider” and collectively as the “Service Providers”) to provide, to the Company (and/or one or more of the Company’s subsidiaries, as applicable,
referred to singly as a “Receiving Party” and collectively, together with the Company, as the “Receiving Parties”) the services listed on Schedule A attached hereto (each, a
“Service” and, collectively, the “Services”). NantBio shall make in its sole discretion any decisions as to which of the Service Providers (including the decisions to use reasonably qualified third parties who are
not Affiliates of NantBio) shall provide the Services. NantBio shall be responsible for the acts and omissions of the Service Providers and each third party Service Provider shall be bound by provisions substantially similar to this Agreement. Each
Service shall be provided and accepted in accordance with the terms, limitations and conditions set forth in this Agreement. 

Section 2.02.    Access. The Company shall, and shall direct its subsidiaries to, (a) make available on a
timely basis to the Service Providers all information and materials reasonably requested by such Service Providers to enable such Service Providers to provide the applicable Services to such Receiving Party; and (b) provide to the Service
Providers reasonable access to the premises of the Receiving Parties and any of their Affiliates to the extent necessary for such Service Providers to provide the applicable Services to the Receiving Parties. NantBio shall, and shall direct its
Affiliates to, create and maintain accurate books and records in connection with providing the Services it performs or causes to be performed hereunder and, upon reasonable notice from Company, shall make available for inspection by Company such
books and records so that Company can substantiate the Service Costs outlined in Schedule A. 

Section 2.03.    Reliance. The Service Providers shall be entitled to rely upon the genuineness, validity or
truthfulness of any document, instrument or other writing presented by the Receiving Parties in 

  
 1 

 
connection with this Agreement. No Service Provider shall be liable for any impairment of any Service caused by its not receiving information, either timely or at all, or by its receiving
inaccurate or incomplete information from the Receiving Parties that is required or reasonably requested regarding that Service. 

Section 2.04.    Cooperation. The Service Providers and the Company shall, and the Company shall cause any of
its subsidiaries that are Receiving Parties hereunder to, cooperate with each other in all reasonable respects in matters relating to the provision and receipt of the Services. 

ARTICLE III 
 TERMS AND CONDITIONS;
PAYMENT; INDEPENDENT CONTRACTORS 
 Section 3.01.    Terms and Conditions of Services. The Service Providers
shall be required to perform the Services using substantially the same quality and standard of care as is used in performing such Services for their own businesses, but in no event less than commercially reasonable care. Without limiting the
generality of the foregoing, the Service Providers shall provide the Services in a manner consistent with NantBio’s provision of such Services for its own business and other portfolio companies. Each Service Provider shall act under this
Agreement solely as an independent contractor and not as an agent or employee of any other Party or any of such Party’s Affiliates, provided any Service Provider other than NantBio shall perform the applicable Services on behalf of NantBio.

 Section 3.02.    Intentionally Omitted. 

Section 3.03.    Payments. In consideration of the Services to be rendered hereunder, the Company shall
compensate NantBio in accordance with Schedule A attached hereto. Each month (or from time to time, at the option of NantBio), NantBio shall deliver an invoice to the Company for Services provided to the Company or its
subsidiaries during the relevant preceding period, and each such invoice shall set forth a brief description of each such Service and a reasonable calculation of the amounts charged for such Service (the “Service Costs”). Payment
with respect to undisputed portions of an invoice shall be due thirty (30) days of the Company’s receipt of an invoice. 

Section 3.04.    Disclaimer of Warranty. EXCEPT AS EXPRESSLY SET FORTH IN THIS AGREEMENT, THE SERVICES TO BE
PURCHASED UNDER THIS AGREEMENT ARE FURNISHED AS IS, WHERE IS, WITH ALL FAULTS AND WITHOUT WARRANTY OF ANY KIND, EXPRESS OR IMPLIED, INCLUDING ANY WARRANTY OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE. 

Section 3.05.    Taxes. NantBio acknowledges and agrees that it shall be NantBio’s obligation to report
as income all compensation received by NantBio pursuant to this Agreement and to pay any withholding taxes, self-employment taxes, and social security, unemployment, workers’ compensation, or disability insurance or similar items, including
interest and penalties thereon, in connection with any payments made to NantBio by the Company for the Services rendered hereunder. 

Section 3.06.    Use of Services. The Company shall not, and shall cause its subsidiaries not to, resell any
Services identified in Schedule A to any person whatsoever or permit the use of the Services identified in Schedule A by any person other than in connection with the conduct of the operations of the Company’s business. 

  
 2 

 ARTICLE IV 

FORCE MAJEURE 

Section 4.01    Force Majeure. Neither Party shall be liable for any expense, loss or damage whatsoever
arising out of any interruption of Service or delay or failure to perform under this Agreement that is due to acts of God, acts of a public enemy, acts of terrorism, acts of a nation or any state, territory, province or other political division
thereof, fires, floods, epidemics, riots, theft, quarantine restrictions, freight embargoes or other similar causes beyond the reasonable control of such Party. In any such event, any Party’s obligations under this Agreement shall be postponed
for such time as its performance is suspended or delayed on account thereof. Each Party will promptly notify the Company upon learning of the occurrence of such event of force majeure. Upon the cessation of the force majeure event, such Service
Provider will use commercially reasonable efforts to resume, or to cause any other relevant Service Provider to resume, its performance with the least practicable delay. 

ARTICLE V 
 LIABILITIES 

Section 5.01.    Punitive and Other Damages. Neither Party shall be liable to the other Party or any of its
Affiliates or their employees, agents, members, managers, officers and directors (collectively, “Representatives”), whether in contract, tort (including negligence and strict liability) or otherwise for any punitive damages
whatsoever which in any way arise out of, relate to or are a consequence of, the performance or nonperformance by a Party (including Affiliates and third-party Service Providers providing Services) hereunder or the provision of, or failure to
provide, any Service hereunder. 
 Section 5.02.    Obligation To
Re-perform. In the event of any breach of this Agreement by any Service Provider with respect to any error, defect or breach (which error, defect, or breach Service Provider can reasonably be expected to
cure by re-performing in a commercially reasonable manner) in the provision of any Service, the Service Provider shall promptly correct in all material respects such error, defect or breach or re-perform in all material respects such Service at the request of the Company and at the expense of the Service Provider. To be effective, any such request for performance by the Company must be in writing that
specifies in reasonable detail the particular error, defect or breach and be made no more than two (2) months from the last date such Service was provided. 

Section 5.03.    Company Indemnity. The Company hereby agrees to indemnify, defend and hold harmless each
Service Provider and each of its Representatives (collectively, the “Indemnitees”) from and against any and all third party claims, demands, complaints, liabilities, losses, damages, costs and expenses (“Damages”)
arising from, relating to or in connection with the use of any Service by the Company or any of its Affiliates, only to the extent that such Damages arise out of, relate to or are a consequence of Company’s bad faith, gross negligence, willful
misconduct or breach of this Agreement. 
 Section 5.04.    NantBio Indemnity. NantBio hereby agrees to
indemnify, defend and hold harmless the Company and its subsidiaries, from and against any and all Damages arising from, relating to or in connection with the use of any Service by the Company or any of the Receiving Parties or any other person
using such Service or in connection with the sale, delivery, provision or use of any Service provided under or covered by this Agreement to the extent that such Damages arise out of, relate to or is a consequence of NantBio or any other of the
Service Providers’ bad faith, gross negligence, willful misconduct, or breach of this Agreement. 

Section 5.05.    Remedies. The Parties agree that monetary damages will not adequately compensate either party
for any breach or threatened breach of this Agreement. Because the breach or threatened breach of this Agreement will result in irreparable injury to the aggrieved Party, such aggrieved 

  
 3 

 
Party shall be entitled to any legal or equitable remedies to enforce such provisions, including specific performance. In all cases, the aggrieved Party shall also be entitled to pursue any other
remedies available at law, including damages, as a result of any such breach. 
 ARTICLE VI 

TERMINATION 

Section 6.01.    Termination. Notwithstanding anything in this Agreement to the contrary, the obligation of
any Service Provider to provide or cause to be provided any Service shall cease on the earliest to occur of the date on which (a) the Company notifies NantBio in writing that it is able to provide such Service for itself and will discontinue
taking such Service, or (b) such Service is terminated by any Party in accordance with the terms of Section 6.02. Unless agreed otherwise by the Parties, after any termination of a Service in accordance with the preceding sentence, NantBio
shall not be obligated to reinstate such Service at a time subsequent to the effective date of such termination. This Agreement shall terminate, and all provisions of this Agreement shall become null and void and of no further force and effect,
except for the provisions set forth in Section 6.04 which shall survive any termination, on the date on which no Service Provider has any obligation to provide any Service under this Agreement. 

Section 6.02.    Breach of Agreement. Subject to Article IV, in the event of a material breach by any
Service Provider or the Company of any of its material obligations under this Agreement, including any failure by the Company to make payments to NantBio when due, which breach is not cured in all material respects within 30 days after written
notice of such breach is provided by the non-breaching Party, the non-breaching Party may terminate (i) this Agreement immediately or (ii) the Service with
respect to which such breach has occurred, in each case by providing written notice of such termination. 

Section 6.03.    Sums Due. In the event of a termination of this Agreement, the Service Providers shall be
entitled to the immediate payment of, and the Company shall within 10 days, pay to NantBio, all accrued amounts for Services and any other amounts due under this Agreement through the effective date of termination (other than in the case of
termination by the Company for breach under Section 6.02). 
 Section 6.04.    Effect of Termination.
Sections 3.03, 3.04, 6.03, and 6.04 and Article I, Article V and Article VII shall survive any termination of this Agreement. 

ARTICLE VII 
 MISCELLANEOUS 

Section 7.01.    Assignment. This Agreement shall be binding upon and inure to the benefit of the Parties and
their respective successors and permitted assigns; provided, that no Party to this Agreement will assign its rights or delegate any or all of its obligations under this Agreement without the express prior written consent of the other Party to
this Agreement; provided, further, that NantBio may assign all or any part of its rights and may assign performance of Services to other Service Providers under this Agreement without obtaining any consent of the Company, provided that in no case
shall such assignment relieve NantBio of any obligations hereunder. Any purported assignment or transfer in violation of this Section 7.01 shall be null and void and of no effect. 

Section 7.02.    Third-Party Beneficiaries. Except as provided in this Section 7.02, this Agreement is
for the sole benefit of the Parties and their permitted successors and assigns, and nothing in this Agreement expressed or implied shall give or be construed to give to any person, other than the Parties and their permitted successors and assigns,
any legal or equitable rights hereunder, whether as third-party beneficiaries or otherwise, except for the Service Providers. 

  
 4 

 Section 7.03.    Amendments. No amendment to this Agreement
shall be effective unless such amendment is in writing and signed by each Party. 

Section 7.04.    Waivers. No failure or delay on the part of any Party in exercising any power or right
hereunder shall operate as a waiver thereof, nor shall any single or partial exercise of any such right or power, or any abandonment or discontinuance of steps to enforce such a right or power, preclude any other or further exercise thereof or the
exercise of any other right or power. The rights and remedies of the Parties hereunder are cumulative and are not exclusive of any rights or remedies which they would otherwise have hereunder. No provision of this Agreement may be waived except
pursuant to a writing executed by the waiving Party. 
 Section 7.05.    Notices. All notices and other
communications to be given to any Party shall be sufficiently given for all purposes hereunder if in writing and delivered by hand, courier or overnight delivery service or three days after being mailed by certified or registered mail, return
receipt requested, with appropriate postage prepaid, or when received in the form of a telegram or facsimile and shall be directed to the address set forth below (or at such other address or facsimile number as such party shall designate by like
notice): 
 (a)    If to NantBio: 

NantBio, Inc. 

9920 Jefferson Boulevard 

Culver City, California 90232 

Attention: General Counsel 

(b)    If to the Company: 

NantCell, Inc. 

9920 Jefferson Boulevard 

Culver City, California 90232 

Attention: Chief Financial Officer 

Section 7.06.    Exhibits and Schedules; Interpretation. The headings contained in this Agreement or in any
Schedule to this Agreement are for reference purposes only and shall not affect in any way the meaning or interpretation of this Agreement. All Schedules referred to in this Agreement are incorporated in and made a part of this Agreement as if set
forth in full in this Agreement. Any capitalized terms used in any Schedule but not otherwise defined in such Schedule shall have the meaning as defined in this Agreement. When a reference is made in this Agreement to an Article, Section or
Schedule, such reference shall be to an Article or Section of, or a Schedule to, this Agreement unless otherwise indicated. For all purposes hereof, the terms “include” and “including” shall be deemed followed by the words
“without limitation”. The words “hereof”, “herein” and “hereunder” and words of similar import when used in this Agreement shall refer to this Agreement as a whole and not to any particular provision of this
Agreement. No provision of this Agreement shall be interpreted or construed against any Party hereto solely because such Party or its legal representative drafted such provision. 

Section 7.07.    Counterparts. This Agreement may be executed in two or more counterparts, all of which shall
be considered one and the same agreement, and shall become effective when one or more counterparts have been signed by each of the Parties and delivered to the other Party. 

  
 5 

 Section 7.08.    Entire Agreement. This Agreement, including
the Schedule to this Agreement, constitutes the entire agreement and understanding between the Parties with respect to the subject matter hereof and supersedes all prior agreements and understandings and negotiations, both written and oral, between
the Parties with respect to the subject matter of this Agreement. No representation, inducement, promise, understanding, condition or warranty not set forth in this Agreement has been made or relied upon by any Party hereto. 

Section 7.09.    Severability. If any term or other provision of this Agreement is invalid, illegal or
incapable of being enforced by any applicable rule of law or public policy, all other conditions and provisions of this Agreement shall nevertheless remain in full force and effect so long as the economic or legal substance of the transactions
contemplated hereby is not affected in any manner materially adverse to any party. Upon such determination that any term or other provision is invalid, illegal or incapable of being enforced, the Parties hereto shall negotiate in good faith to
modify this Agreement so as to effect the original intent of the Parties as closely as possible in an acceptable manner to the end that transactions contemplated hereby are fulfilled to the extent possible. 

Section 7.10.    Governing Law and Dispute Resolution. This Agreement will be governed by and construed in
accordance with the laws of the State of Delaware applicable to agreements made and to be performed wholly within that State without regard to its conflicts of laws provisions. Any claim or controversy between the Parties arising out of the
circumstances and relationships contemplated by this Agreement, including disputes relating to the validity, construction or interpretation of this Agreement (“Disputes”), shall, upon written notice of the Company to NantBio or
NantBio to the Company, as applicable, be referred for resolution by final, binding arbitration in accordance with the provisions of this Section 7.10. The arbitration shall be conducted by the Judicial Arbitration and Mediation Services, Inc.
(or any successor entity thereto) (“JAMS”) under its rules of arbitration then in effect, except as modified in this Agreement. The arbitration shall be conducted in the English language, by a single arbitrator. The arbitrator shall
engage an independent expert with experience in the subject matter of the Dispute to advise the arbitrator. With respect to any Dispute arising under this Agreement, the Parties and the arbitrator shall use all reasonable efforts to complete any
such arbitration within six (6) months from the issuance of notice of a referral of any such Dispute to arbitration. The arbitrator shall determine what discovery will be permitted, consistent with the goal of limiting the cost and time which
the Parties must expend for discovery; provided that the arbitrator shall permit such discovery as he or she deems necessary to permit an equitable resolution of the Dispute. The Parties agree that the decision of the arbitrator shall be the sole,
exclusive and binding remedy between them regarding the Dispute presented to the arbitrator. Any decision of the arbitrator may be entered in a court of competent jurisdiction for judicial recognition of the decision and an order of enforcement. The
arbitration proceedings and the decision of the arbitrator shall not be made public without the mutual consent of the Parties and each Party shall maintain the confidentiality of such proceedings and decision unless each Party otherwise agrees in
writing; provided that a Party may make such disclosures as are permitted for confidential information under Section 7.11 below. Unless otherwise mutually agreed upon by the Parties, the arbitration proceedings shall be conducted in the County
of Los Angeles in the State of California. The Parties agree that they shall share equally the cost of the arbitration filing and hearing fees, the cost of the independent expert retained by the arbitrator, and the cost of the arbitrator and
administrative fees of JAMS. Each Party shall bear its own costs and attorneys’ and witnesses’ fees and associated costs and expenses. Pending the selection of the arbitrator or pending the arbitrator’s determination of the merits of
any Dispute, a Party may seek appropriate interim or provisional relief from any court of competent jurisdiction as necessary to protect the rights or property of that Party. 

Section 7.11.    Confidentiality. Each of the Parties agrees that any confidential information of the other
Party disclosed, received, or discovered in the course of performance under this Agreement, (“Confidential Information”) shall be kept strictly confidential by the Parties and may be used by the recipient only as necessary to
perform its obligations or exercise or enforce its rights under this Agreement, 

  
 6 

 
except that either Party may, (i) for the purpose of providing Services pursuant to this Agreement, disclose such Confidential Information, on a need-to-know basis, to any of its respective Affiliates or to third-party Service Providers; provided, that any such third party shall have agreed to be bound by this Section 7.11 and (ii) disclose
such Confidential Information to the extent reasonably necessary in connection with the enforcement of this Agreement or as required by law or legal process, including any tax audit or litigation. The obligations under this Section 7.11 shall
not apply to (i) information that is already in the possession of the Party receiving confidential information, provided that such information is not known by such Party to be subject to another confidentiality agreement with or other
obligation of secrecy to the other Party or another party; (ii) information that becomes available to the public other than as a result of a disclosure, directly or indirectly, by the Party receiving Confidential Information or its Affiliates;
or (iii) information that becomes available to the Party receiving Confidential Information on a non-confidential basis from a source other than the other Party; provided that such source is not known by
such party to be bound by a confidentiality agreement with or other obligation of secrecy to the other Party. 
 [Remainder of page left
intentionally blank] 

  
 7 

 IN WITNESS WHEREOF, the Parties have executed this Shared Services Agreement as of the date
first written above. 
  

			
	NANTBIO, INC.
		
	By:	 	 /s/ A. James Banaag

	Name:	 	A. James Banaag
	Title:	 	Chief Financial Officer
	
	NANTCELL, NC.
		
	By:	 	 /s/ Robert Morse

	Name:	 	Robert Morse
	Title:	 	Chief Financial Officer

 Signature Page to Shared Services Agreement 

 SCHEDULE A 

Schedule of Services and Compensation 

NantBio and/or its Affiliates shall provide (or cause to be provided) the following corporate, general and administrative and other support services to
Company and its Affiliates and subsidiaries: 
  

	 	•	 	 Employee benefit expenses, including, without limitation, costs for medical and health insurance, retirement,
401k, and life insurance. 

 In compensation for the Services: 
  

	 	•	 	 The Receiving Party will be charged for such Services at cost (without
mark-up or profit for NantBio, but including reasonable allocations of employee benefits, facilities and other direct and fairly allocated indirect costs that relate to the employees or consultants providing
the Services) based whenever possible on identification of specific costs as identifiable within NantBio’s books and records (e.g., specific salaries for the individuals providing Services) and where such specific identification is not
possible, based upon good faith allocations determined by analysis performed by finance department head of such Party providing the Services and made in a manner consistent with NantBio’s provision of such Services for its subsidiaries and
portfolio companies as of the Effective Date. 

  
 SCHEDULE A

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00319-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00319-of-00352.parquet"}]]